
About Lyratone
Hearing technology's AI moment needed a foundation. We spent seven years building it.
Founded in 2018, Lyratone Technologies specializes in the research and development of cutting-edge hearing health solutions. By integrating Software-Defined Hearing (SDH) and artificial intelligence with advanced acoustic technology, we're redefining the future of hearing aids — full-stack, for the B2B market.
Company Overview
Lyratone focuses on the B2B market, providing enterprise customers with full-stack medical hearing aid and assistive hearing solutions — algorithms, integrated motherboards, complete devices, and fitting/tuning software. Our hearing aids are certified as Class II medical devices by the US FDA. Every product runs on the same self-developed Software-Defined Hearing architecture, and every partner chooses how much of that stack to own — from licensing the software alone to a full turnkey device.
Our vision
Better hearing for better life.
We believe better hearing changes lives — and that the fastest way to reach more of them is through partners, not just direct-to-consumer products. Lyratone exists to give hearing-technology brands a platform they can trust: reliable enough to build a business on, and advanced enough to keep them competitive as the category evolves.
Development history
2018
- Lyratone Technologies was founded.
2019
- Lyratone Hearing App launched (iOS/Android), combining hearing test and hearing-aid function — around 250,000 users to date.
- First Software-Defined Hearing (SDH) -based hearing aid and embedded SoC R&D begins using Qualcomm 5124 chipset.
2021
- First commercial LyraOS embedded SDK ships, enabling a top-tier earbud brand to add hearing features to consumer electronics.
2022
- Major LyraOS upgrades for prescription air-conduction devices.
2023
- First full-device air-conduction hearing aid launches — US FDA OTC certified, 32-band WDRC on a 12nm chipset.
2024
- First bone-conduction hearing aid, developed with a strategic partner, with Lyratone supplying the LyraOS-embedded PCBA. Open-ear (OWS) development completed.
2025
- Continued focus on air-conduction, bone-conduction, and open-ear devices — all on a 12nm SDH architecture, versus the roughly 56nm typical of hardware-defined competitors. Multiple partner-collaboration hearing aids went to market.
Where we are
China
Building 2-1F, No. 40 Beiyuan Road,
Chaoyang District.
Beijing, 100012
China
US
750 Alma Ln, Suite 4601,
Foster City,
CA 94404,
USA.
© Copyright - 2009-2026 : All Rights Reserved.

